期刊文献+

血液透析患者血清尿酸与C反应蛋白水平的相关研究 被引量:7

Serum Uric Acid Correlates with C-Reactive Protein Level in Hemodialysis Patients
下载PDF
导出
摘要 目的:验证血清尿酸(SUA)与C反应蛋白(CRP)的关系及两者在血液透析患者心血管事件发生中是否存在协同作用。方法:本研究入组的67例患者均为在我院血净中心进行常规血液透析(透析龄≥3个月)的患者。所有患者均无明显感染和传染性疾病病史。检测患者的基线SUA、CRP、KT/V及其他临床指标。并对患者进行了6个月的随访,以观察高尿酸血症合并CRP升高对血液透析患者心血管并发症的影响。结果:67例患者均完成了6个月的随访,未出现死亡病例。入组时平均SUA水平为(459.6±128.9)μmol/L,其中高尿酸血症患者38例(56.7%);CRP升高者35例(52.2%)。高尿酸血症伴CRP升高者24例(35.8%)。多元回归分析显示,在进行年龄、性别、体重、Kt/V、三酰甘油、吸烟史、糖尿病病史、高血压等校正后,血清尿酸仍与CRP-log明显相关关系(OR:2.24,Z=2.24,P=0.001)。随访6个月,67例血液透析患者中共有26例(38.8%)患者发生心血管事件,其中高尿酸血症伴CRP升高组心血管事件发生率70.8%(17/24);单纯高尿酸血症组27.3%(3/11);单纯CRP升高组28.6%(4/14)血清尿酸及CRP水平均正常组11.1%(2/18)。结论:血液透析患者的血清尿酸水平与C反应蛋白水平可能相关。高尿酸血症与CRP共同作用可增加血液透析患者心血管事件的发生率。 Objective:To investigate the relationship serum uric acid (SUA) and C- reactive protein (CRP) and their cooperation in cardiovascular risk. Methods: This study included 67 maintenance hemodialysis patients(time for hemodialysis≥3 month) who were followed-up for more than 6 months in our blood purification center. The baseline included SUA,CRP,KT/V and other clinical index. Results:All of 67 patients complete 6 - month follow - up, including hyperuricenfia 38 (56.7%), elevated CRP 35 (52.2%) and hyperuricemia wth elevated CRP 24 (35.83%). Multiple regression analysis showed that the serum uric acid positive correlated to CRP - log even corrected by age, gender, weight, KT/V,serum triglyceride, history of smoke, diabetes and hypertension. Cardiovascular events occurred in 26 patients (26/67, 38.8% ), 17/24(70.8% ) in hyperuricemia and elevated CRP group, 3/11(27.3 % ) in single hyperuricemia group, 4/14 (28.6 % ) in single elevated CRP group and 2/18 (11.1% ). Conclusion: The serum uric acid level in hemodialysis could be positive correlated to CRP level. Their cooperation could increase the incidence of cardiovascular disease in hemodialysis patients.
出处 《中国中西医结合肾病杂志》 2008年第3期228-230,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 国家自然科学基金资助项目(No30670983)
关键词 血液透析 血清尿酸 C反应蛋白 心血管疾病 Hemodialysis Serum uricacid C- reactive protein Cardiovascular disease
  • 相关文献

参考文献5

  • 1Wanner C, Metzger T. C - reactive protein a marker for all - cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant, 2002,17 (Suppl 8) : 29 - 32.
  • 2Hakoda M,Masunari N, Yamada M,et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors. J Rheumatol,2005,32(5):906 - 912.
  • 3Kang DH, Park SK, Lee IK, et al. Uric acid - induced C - reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol,2005,16(12):3553 - 3562.
  • 4Ronco C, Bowry S, Tetta C. Dialysis patients and cardiovascular problems: Can technology help solve the complex equation? Blood Purif, 2006,24 ( 1 ) : 39 - 45.
  • 5邱强,陈香美,谢院生,魏日胞,吴镝,蔡广研,刘述文.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6):329-331. 被引量:43

二级参考文献10

  • 1陈香美,谢院生.重视延缓IgA肾病进展的基础和临床研究[J].中华肾脏病杂志,2004,20(4):235-237. 被引量:155
  • 2Syrjanen J,Mustonen J,Pasternack A.Hypertrigly ceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant,2000,15(1):34-42.
  • 3Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension,2003,41(6):1183-1190.
  • 4Wu J,Chen X, Xie Y,et al.Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant,2005,20(4):719-727.
  • 5Katafuchi R, Kiyoshi Y,Oh Y,et al.Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol,1998,49(1):1-8.
  • 6Johnson RJ,Schreiner GF.The role of acquired tubuloterstial disease in the paphogenesis of salt dependent hypertension. Kidney Int,1997,52(5):1169-1179.
  • 7Tinahones JF,Perez-Lindon G,C-Soriguer FJ,et al.Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab,1997,82(4):1188-1191.
  • 8Kang DH,Nakagawa T,Feng L,et al.A role for uric acid in the progression of renal disease.J Am Soc Nephrol,2002,13(12):2888-2897.
  • 9Sanchez-Lozada LG,Tapia E,Santamaria J,et al.Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.Kidney Int,2005,67(1):237-247.
  • 10张燕平,陈香美,庄永泽,危成筠,石晓云.肾小管间质损害在IgA肾病中的临床意义[J].中华内科杂志,2001,40(9):613-617. 被引量:94

共引文献42

同被引文献53

  • 1冯缨缨,王蓓芸,崔亮,梁瑞廉.高血压病合并高尿酸血症与C反应蛋白的关系分析[J].中国临床医学,2006,13(1):7-9. 被引量:1
  • 2邹贵勉(综述),眭维国,邹和群(审校).尿酸与高血压及动脉硬化的关系[J].国际泌尿系统杂志,2007,27(3):383-385. 被引量:9
  • 3江静,丁小强,方艺.维持性血液透析患者C-反应蛋白与前白蛋白的关系[J].中国临床医学,2007,14(3):434-435. 被引量:2
  • 4CHEN Li-ying ZHU Wen-hua CHEN Zhou-wen DAI Hong-lei REN Jing-jing CHEN Jian-hua CHEN Lei-qian FANG Li-zheng.Relationship between hyperuricemia and metabolic syndrome[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2007,8(8):593-598. 被引量:54
  • 5Panichi V, Migliori M,De Pietro S, et al. C- reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif, 2000,18(3) : 183 - 190.
  • 6Trine M, Helle AS, Vibeke EH, et al. C - reactive protein, dietary ω - 3 fatty acids and the extent of coronary artery disease. Am J Cardiol,2001,88(10):1139- 1142.
  • 7Antonin M,Gotto AM Fr. Role of C- reactive protein in coronary risk reduction foc on primary prevention. Am J Cardiol, 2007,99(5):718 - 725.
  • 8Hans,son GK. Inflammation, atherosclerosis and Coronary arery disease. N Engl J Med,2005,352(16) : 1685 - 1695.
  • 9Zoccali C, MaUamaci F, Tripepi G. Novel cardiovascular risk factors in end - stage renal disease. J Am Soc Nephrol, 2004, 15 (Suppl) :S77 - 880.
  • 10Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic rinal failure. Kidney Int, 1999,55(5):1899 - 1911.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部